Alpha 2.0
Login Register
» Authors » Robert Schnoll

Robert Schnoll

Explore the profile of Robert Schnoll including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 415
Followers 0
Related Specialties
Psychiatry
Public Health
Oncology
Top 10 Co-Authors
E Paul Wileyto
Frank Leone
Robert Gross
Brian Hitsman
Anna-Marika Bauer
Rachel F Tyndale
Rebecca L Ashare
Frank T Leone
Peter Gabriel
Daniel Blumenthal
Published In
Nicotine Tob Res
Addict Behav
Implement Sci
Ann Am Thorac Soc
Psychooncology
Affiliations
Soon will be listed here.
Recent Articles
1.
Predictive Value of Individual Behavioral Risk Factors for New Mood-Related Psychiatric Disorder After Diagnosis of Cancer
Villalona S, Chavez Perez C, Wileyto E, Takvorian S, Gabriel P, Doucette A, et al.
Psychooncology . 2024 Dec; 33(12):e70046. PMID: 39702888
Objective: The diagnosis of a mood-related psychiatric disorder (MRPD) among patients with cancer has been associated with decreased quality of life and lower cancer survival. This study aimed to understand...
2.
Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control
Schnoll R, Bekelman J, Blumenthal D, Asch D, Buttenheim A, Chaiyachati K, et al.
J Clin Transl Sci . 2024 Dec; 8(1):e166. PMID: 39619072
Traditional approaches for evaluating the impact of scientific research - mainly scholarship (i.e., publications, presentations) and grant funding - fail to capture the full extent of contributions that come from...
3.
A pilot pragmatic randomized controlled trial of a nicotine metabolite ratio-guided smoking cessation intervention in a lung health and screening program
Siegel S, Budziszewski R, Layton E, Nam B, Schnoll R
Drug Alcohol Depend Rep . 2024 Sep; 12:100275. PMID: 39253369
Introduction: Patients with pulmonary nodules detected through lung cancer screening or as incidental findings are often followed in lung health and screening programs. The use of personalized pharmacotherapy for smoking...
4.
Clinician- and Patient-Directed Communication Strategies for Patients With Cancer at High Mortality Risk: A Cluster Randomized Trial
Takvorian S, Gabriel P, Wileyto E, Blumenthal D, Tejada S, Clifton A, et al.
JAMA Netw Open . 2024 Jul; 7(7):e2418639. PMID: 38949813
Importance: Serious illness conversations (SICs) that elicit patients' values, goals, and care preferences reduce anxiety and depression and improve quality of life, but occur infrequently for patients with cancer. Behavioral...
5.
A Pilot Study to Evaluate the Use of Automated Nicotine Metabolite Ratio Reporting Within Primary Care as an Implementation Strategy to Increase the Use of Tobacco Treatments
Schnoll R, Leone F, Bauer A, Wileyto E, Wollack C, Stevens N, et al.
Nicotine Tob Res . 2024 May; 26(11):1570-1575. PMID: 38779826
Introduction: Concerns about safety and effectiveness of tobacco treatments reduce their use. We explored integrating the nicotine metabolite ratio (NMR), and messaging about its potential for improving safety and effectiveness,...
6.
Protocol for a pragmatic stepped wedge cluster randomized clinical trial testing behavioral economic implementation strategies to increase supplemental breast MRI screening among patients with extremely dense breasts
McCarthy A, Fernandez Perez C, Beidas R, Bekelman J, Blumenthal D, Mack E, et al.
Implement Sci . 2023 Nov; 18(1):65. PMID: 38001506
Background: Increased breast density augments breast cancer risk and reduces mammography sensitivity. Supplemental breast MRI screening can significantly increase cancer detection among women with dense breasts. However, few women undergo...
7.
Seeing Through the Blind: Belief About Treatment Randomization and Smoking Cessation Outcome Among People With Current or Past Major Depressive Disorder Who Smoke in a Placebo-Controlled Trial of Varenicline
Schnoll R, Wileyto E, Bauer A, Fox E, Blumenthal D, Hosie Quinn M, et al.
Nicotine Tob Res . 2023 Nov; 26(5):597-603. PMID: 37934573
Introduction: Blinding participants to randomization is a cornerstone of science. However, participant beliefs about their allocation can influence outcomes. We examined blind integrity, the association between trial arm belief and...
8.
Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices
Symecko H, Schnoll R, Beidas R, Bekelman J, Blumenthal D, Bauer A, et al.
Implement Sci . 2023 Nov; 18(1):57. PMID: 37932730
Background: Germline genetic testing is recommended by the National Comprehensive Cancer Network (NCCN) for individuals including, but not limited to, those with a personal history of ovarian cancer, young-onset (< ...
9.
Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz-Based Therapy in People With HIV Who Smoke
Medaglio D, Bilker W, Han X, Merlin J, Plankey M, Martin J, et al.
Clin Pharmacol Ther . 2023 Oct; 115(1):80-85. PMID: 37787039
Rates of cigarette smoking in people with HIV (PWH) are two to three times higher than in people without HIV. Nicotine is metabolized by CYP2A6 and the nicotine metabolite ratio...
10.
Participatory logic modeling in a multi-site initiative to advance implementation science
Easterling D, Jacob R, Brownson R, Haire-Joshu D, Gundersen D, Angier H, et al.
Implement Sci Commun . 2023 Aug; 4(1):106. PMID: 37644495
Background: Logic models map the short-term and long-term outcomes that are expected to occur with a program, and thus are an essential tool for evaluation. Funding agencies, especially in the...